Human cytomegalovirus downregulates the expression of human class I major histocompatibility complex (MHC) molecules by accelerating destruction of newly synthesized class I heavy chains. The HCMV genome contains at least two genes, US11 and US2, each of which encode a product sufficient for causing the dislocation of newly synthesized class I heavy chains from the lumen of the endoplasmic reticulum to the cytosol. Based on a comparison of their abilities to degrade the murine class I molecules H-2Kb, Kd, Db, Dd, and Ld, the US11 and US2 gene products have non-identical specificities for class I molecules. Specifically, in human astrocytoma cells (U373-MG) transfected with the US11 gene, the Kb, Db, Dd, and Ld molecules expressed via recombinant vaccinia virus are rapidly degraded, whereas in US2-transfected cells, only Db and Dd are significantly destabilized. The diversity in HCMV-encoded functions that interfere with class I–restricted presentation likely evolved in response to the polymorphism of the MHC.
Article navigation
20 January 1997
Brief Definitive Report|
January 20 1997
The HCMV Gene Products US11 and US2 Differ in Their Ability to Attack Allelic Forms of Murine Major Histocompatibility Complex (MHC) Class I Heavy Chains
Robert P. Machold,
Robert P. Machold
From the *Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and ‡Department of Molecular Biology, Infectious Diseases Section, Wyeth-Ayerst Research, Pearl River, New York 10965
Search for other works by this author on:
Emmanuel J.H.J. Wiertz,
Emmanuel J.H.J. Wiertz
From the *Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and ‡Department of Molecular Biology, Infectious Diseases Section, Wyeth-Ayerst Research, Pearl River, New York 10965
Search for other works by this author on:
Thomas R. Jones,
Thomas R. Jones
From the *Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and ‡Department of Molecular Biology, Infectious Diseases Section, Wyeth-Ayerst Research, Pearl River, New York 10965
Search for other works by this author on:
H.L. Ploegh
H.L. Ploegh
From the *Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and ‡Department of Molecular Biology, Infectious Diseases Section, Wyeth-Ayerst Research, Pearl River, New York 10965
Search for other works by this author on:
Robert P. Machold,
Emmanuel J.H.J. Wiertz,
Thomas R. Jones,
H.L. Ploegh
From the *Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and ‡Department of Molecular Biology, Infectious Diseases Section, Wyeth-Ayerst Research, Pearl River, New York 10965
Address correspondence to Hidde Ploegh, Center for Cancer Research, MIT, 40 Ames St. E17-322, Cambridge, MA 02139.
This work was supported by National Institutes of Health grants R01-AI33456 and R01-AI07463-17, and by Boehringer-Ingelheim.
Received:
September 20 1996
Revision Received:
November 26 1996
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 185 (2): 363–366.
Article history
Received:
September 20 1996
Revision Received:
November 26 1996
Citation
Robert P. Machold, Emmanuel J.H.J. Wiertz, Thomas R. Jones, H.L. Ploegh; The HCMV Gene Products US11 and US2 Differ in Their Ability to Attack Allelic Forms of Murine Major Histocompatibility Complex (MHC) Class I Heavy Chains. J Exp Med 20 January 1997; 185 (2): 363–366. doi: https://doi.org/10.1084/jem.185.2.363
Download citation file:
Sign in
Don't already have an account? Register
Suggested Content
Email alerts
Advertisement
